Auteurs

[:fr]Francesco Puleo[:],
[:fr]Jeremy Augustin[:],
[:fr]Jean-Francois Emile[:],
[:fr]Magali Svrcek[:],
[:fr]Tatjana Arsenijevic[:],
[:fr]Jean-Luc Van Laethem[:],
[:fr]Jean-Baptiste Bachet[:],

Abstract

Background

Few patients with pancreatic adenocarcinoma (PAC) are eligible for surgery. Patients with early relapse have a poor prognosis and might be better candidates for a medical approach. Clinical and pathological parameters only partially predict recurrence and are only obtained after surgery. PAC subtypes based on gene expression were proposed, and we assessed if they could predict the risk and type of recurrence independently of clinicopathological parameters.

Methods

Patients with curative-intent surgery for PAC without pretreatment were selected and divided into two independent cohorts defined as discovery (n = 381) and validation (n = 149) cohorts. Transcriptomic analyses were performed on formalin-fixed paraffin-embedded surgical samples to characterise tumour and stroma compartments using previously defined signatures. We associated molecular and clinicopathological characteristics with general, distant, and local recurrences using Cox regression analyses.

Results

We found that tumour biology predicted distant recurrence contrary to local recurrence, which was directly related to resection margin status. Pure basal-like and stroma-activated subtypes were strongly associated with distant recurrence, independently of clinicopathological factors (hazard ratios [HRs] = 5.85, p < 0.001 and HR = 1.75, p = 0.007, respectively). By dissecting tumoural and stromal compartments, we demonstrated that the basal-like tumour component positively correlated with distant recurrence in both cohorts (HR = 1.45, p < 0.001 and HR = 1.90, p < 0.001), whereas the inactive structural stroma component was protective against distant recurrence (HR = 0.68, p < 0.001 and HR = 0.72, p < 0.001).

Conclusions

In addition to suggesting a different mechanism for local and distant relapse (incomplete resection and high metastatic potential, respectively), our results show the potency of molecular phenotype to predict patient outcome regarding distant recurrences.

Autres publications

Auteurs :
Marc Hilmi,
Flore Delecourt,
Jérome Raffenne,
Taib Bourega,
Nelson Dusetti,
Juan Iovanna,
Yuna Blum,
Magali Richard,
Cindy Neuzillet,
Anne Couvelard,
Matthieu Tihy,
Mestier Louis De,
Vinciane Rebours,
Rémy Nicolle,
Jérome Cros,
En savoir +
Auteurs :
Yohann Loriot,
Maud Kamal,
Laurene Syx,
Rémy Nicolle,
Celia Dupain,
Naoual Mensourri,
Igor Duquesne,
Pernelle Lavaud,
Claudio Nicotra,
Maud Ngocamus,
Ludovic Lacroix,
Lambros Tselikas,
Gilles Crehange,
Luc Friboulet,
Zahra Castel-Ajgal,
Yann Neuzillet,
Edith Borcoman,
Philippe Beuzeboc,
Grégoire Marret,
Tom Gutman,
Jennifer Wong,
Francois Radvanyi,
Sylvain Dureau,
Jean-Yves Scoazec,
Nicolas Servant,
Yves Allory,
Benjamin Besse,
Fabrice Andre,
Christophe Le Tourneau,
Christophe Massard,
Ivan Bieche,
En savoir +
Auteurs :
Marc Hilmi,
Matthieu Delaye,
Milena Muzzolini,
Rémy Nicolle,
Jérome Cros,
Pascal Hammel,
Victoire Cardot-Ruffino,
Cindy Neuzillet,
En savoir +
Auteurs :
Rémy Nicolle,
Jean-Baptiste Bachet,
Alexandre Harlé,
Juan Iovanna,
Pascal Hammel,
Vinciane Rebours,
Anthony Turpin,
Meher Ben Abdelghani,
Alice Wei,
Emmanuel Mitry,
Anthony Lopez,
James Biagi,
Eric François,
Pascal Artru,
Aurélien Lambert,
Daniel J Renouf,
Laure Monard,
Marjorie Mauduit,
Nelson Dusetti,
Thierry Conroy,
Jérome Cros,
En savoir +